These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12693402)

  • 21. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
    Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Choosing a drug-eluting stent: a comparison between CYPHER and TAXUS.
    Perin EC
    Rev Cardiovasc Med; 2005; 6 Suppl 1():S13-21. PubMed ID: 15665793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of drug-eluting stents.
    Williams DO; Kereiakes DJ
    Rev Cardiovasc Med; 2005; 6 Suppl 1():S22-30. PubMed ID: 15665794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy.
    Saia F; Lemos PA; Sianos G; Degertekin M; Lee CH; Arampatzis CA; Hoye A; Tanabe K; Regar E; van der Giessen WJ; Smits PC; de Feyter P; Ligthart J; van Domburg RT; Serruys PW
    Am J Cardiol; 2003 Jul; 92(2):200-3. PubMed ID: 12860224
    [No Abstract]   [Full Text] [Related]  

  • 25. Day in and day out.
    Holmes DR
    Catheter Cardiovasc Interv; 2004 May; 62(1):30. PubMed ID: 15103596
    [No Abstract]   [Full Text] [Related]  

  • 26. [Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].
    Zahn R; Hamm CW; Zeymer U; Schneider S; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Schöbel WA; Sabin G; Senges J;
    Herz; 2004 Mar; 29(2):181-6. PubMed ID: 15057439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute and intermediate-term procedural results using cypher stenting to treat multi-vessel coronary artery disease.
    Kornowski R; Vaknin-Assa H; Assali A; Fuchs S
    Int J Cardiovasc Intervent; 2005; 7(3):122-5. PubMed ID: 16243732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The future of CART in the era of drug eluting stents: "It's not over until it's over". Counterpoint.
    Tripuraneni P
    Brachytherapy; 2003; 2(2):74-6. PubMed ID: 15062143
    [No Abstract]   [Full Text] [Related]  

  • 29. Double jeopardy: balance between bleeding and stent thrombosis with prolonged dual antiplatelet therapy after drug-eluting stent implantation.
    Yan BP; Gurvitch R; Ajani AE
    Cardiovasc Revasc Med; 2006; 7(3):155-8. PubMed ID: 16945822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug-eluting stents: breakthrough or time bomb].
    Lüscher TF; Silber S
    Herz; 2007 Jun; 32(4):265-7. PubMed ID: 17607531
    [No Abstract]   [Full Text] [Related]  

  • 31. Living the dream of no restenosis.
    Teirstein PS
    Circulation; 2001 Oct; 104(17):1996-8. PubMed ID: 11673334
    [No Abstract]   [Full Text] [Related]  

  • 32. [The Nordic Bifurcation Study. Randomized study on the question of optimal stenting technique for bifurcating stenosis].
    Herz; 2006 May; 31(3):257. PubMed ID: 17431944
    [No Abstract]   [Full Text] [Related]  

  • 33. The future of coronary artery radiation therapy--"the CART before the (unbridled) horse!". Point.
    Devlin PM
    Brachytherapy; 2003; 2(2):73-4. PubMed ID: 15062142
    [No Abstract]   [Full Text] [Related]  

  • 34. Angioscopic findings after drug-eluting stent implantation.
    Takano M; Mizuno K
    Herz; 2007 Jun; 32(4):281-6. PubMed ID: 17607534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model.
    Collingwood R; Gibson L; Sedlik S; Virmani R; Carter AJ
    Catheter Cardiovasc Interv; 2005 Jun; 65(2):227-32. PubMed ID: 15900559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radionuclides-hyaluronan-conjugate thromboresistant coatings to prevent in-stent restenosis.
    Thierry B; Winnik FM; Merhi Y; Silver J; Tabrizian M
    Biomaterials; 2004 Aug; 25(17):3895-905. PubMed ID: 15020166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular basis of restenosis and drug-eluting stents.
    Costa MA; Simon DI
    Circulation; 2005 May; 111(17):2257-73. PubMed ID: 15867193
    [No Abstract]   [Full Text] [Related]  

  • 38. Inflammatory reactions to endografts: The causes remain obscure.
    Veith FJ
    J Endovasc Surg; 1997 Nov; 4(4):361. PubMed ID: 9418199
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug-eluting stents: the panacea for restenosis?
    Lim MC
    Singapore Med J; 2004 Jul; 45(7):300-2. PubMed ID: 15221043
    [No Abstract]   [Full Text] [Related]  

  • 40. Endothelial progenitor cell-coated stents under scrutiny.
    Szmitko PE; Kutryk MJ; Stewart DJ; Strauss MH; Verma S
    Can J Cardiol; 2006 Nov; 22(13):1117-9. PubMed ID: 17102828
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.